These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10584558)

  • 1. Genetic variants of the tuberous sclerosis 2 tumour suppressor gene in mouse t haplotypes.
    Kleymenova EV; Declue JE; Walker CL
    Genet Res; 1999 Oct; 74(2):139-44. PubMed ID: 10584558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development.
    Rennebeck G; Kleymenova EV; Anderson R; Yeung RS; Artzt K; Walker CL
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15629-34. PubMed ID: 9861021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutations detected in the TSC2 gene from both sporadic and familial TSC patients.
    Wilson PJ; Ramesh V; Kristiansen A; Bove C; Jozwiak S; Kwiatkowski DJ; Short MP; Haines JL
    Hum Mol Genet; 1996 Feb; 5(2):249-56. PubMed ID: 8824881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germ-line mosaicism in tuberous sclerosis: how common?
    Rose VM; Au KS; Pollom G; Roach ES; Prashner HR; Northrup H
    Am J Hum Genet; 1999 Apr; 64(4):986-92. PubMed ID: 10090883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex.
    Ali M; Girimaji SC; Markandaya M; Shukla AK; Sacchidanand S; Kumar A
    Acta Neurol Scand; 2005 Jan; 111(1):54-63. PubMed ID: 15595939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation and polymorphism analysis in the tuberous sclerosis 2 (TSC2) gene.
    Gilbert JR; Guy V; Kumar A; Wolpert C; Kandt R; Aylesworth A; Roses AD; Pericak-Vance MA
    Neurogenetics; 1998 Aug; 1(4):267-72. PubMed ID: 10732801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34.
    van Slegtenhorst M; de Hoogt R; Hermans C; Nellist M; Janssen B; Verhoef S; Lindhout D; van den Ouweland A; Halley D; Young J; Burley M; Jeremiah S; Woodward K; Nahmias J; Fox M; Ekong R; Osborne J; Wolfe J; Povey S; Snell RG; Cheadle JP; Jones AC; Tachataki M; Ravine D; Sampson JR; Reeve MP; Richardson P; Wilmer F; Munro C; Hawkins TL; Sepp T; Ali JB; Ward S; Green AJ; Yates JR; Kwiatkowska J; Henske EP; Short MP; Haines JH; Jozwiak S; Kwiatkowski DJ
    Science; 1997 Aug; 277(5327):805-8. PubMed ID: 9242607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity.
    Wienecke R; König A; DeClue JE
    J Biol Chem; 1995 Jul; 270(27):16409-14. PubMed ID: 7608212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberous sclerosis: between genetic and physical analysis.
    Halley DJ
    Acta Genet Med Gemellol (Roma); 1996; 45(1-2):63-75. PubMed ID: 8872012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformation of kidney epithelial cells by a quinol thioether via inactivation of the tuberous sclerosis-2 tumor suppressor gene.
    Yoon HS; Monks TJ; Walker CL; Lau SS
    Mol Carcinog; 2001 May; 31(1):37-45. PubMed ID: 11398196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological mutations in TSC1 and TSC2 disrupt the interaction between hamartin and tuberin.
    Hodges AK; Li S; Maynard J; Parry L; Braverman R; Cheadle JP; DeClue JE; Sampson JR
    Hum Mol Genet; 2001 Dec; 10(25):2899-905. PubMed ID: 11741833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region.
    Jin F; Wienecke R; Xiao GH; Maize JC; DeClue JE; Yeung RS
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9154-9. PubMed ID: 8799170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours.
    Knowles MA; Hornigold N; Pitt E
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):597-602. PubMed ID: 12773163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three novel types of splicing aberrations in the tuberous sclerosis TSC2 gene caused by mutations apart from splice consensus sequences.
    Mayer K; Ballhausen W; Leistner W; Rott H
    Biochim Biophys Acta; 2000 Nov; 1502(3):495-507. PubMed ID: 11068191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the tuberous sclerosis gene TSC2 in patients with pulmonary lymphangioleiomyomatosis.
    Astrinidis A; Khare L; Carsillo T; Smolarek T; Au KS; Northrup H; Henske EP
    J Med Genet; 2000 Jan; 37(1):55-7. PubMed ID: 10633137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins.
    Nellist M; Goedbloed MA; Halley DJ
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):587-91. PubMed ID: 12773161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis.
    Maheshwar MM; Cheadle JP; Jones AC; Myring J; Fryer AE; Harris PC; Sampson JR
    Hum Mol Genet; 1997 Oct; 6(11):1991-6. PubMed ID: 9302281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of expression of tuberin, the tuberous-sclerosis-complex-gene-2 product in tuberous sclerosis complex associated connective tissue nevi and sporadic squamous and basal cell carcinomas.
    Wienecke R; Klemm E; Karparti S; Swanson NA; Green AJ; DeClue JE
    J Cutan Pathol; 2002 May; 29(5):287-90. PubMed ID: 12100629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of gene mutation in patients with tuberous sclerosis complex with polymerase chain reaction-single strand conformation polymorphism].
    Feng JH; Ding MP; Yang CW
    Zhonghua Er Ke Za Zhi; 2003 Mar; 41(3):223-6. PubMed ID: 14756965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis.
    Strizheva GD; Carsillo T; Kruger WD; Sullivan EJ; Ryu JH; Henske EP
    Am J Respir Crit Care Med; 2001 Jan; 163(1):253-8. PubMed ID: 11208653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.